Meeder Asset Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-668
Closed -$28K 1340
2022
Q3
$28K Sell
668
-214
-24% -$11K ﹤0.01% 1000
2022
Q2
$48K Sell
882
-703
-44% -$42.2K ﹤0.01% 877
2022
Q1
$102K Sell
1,585
-20
-1% -$1.32K 0.01% 788
2021
Q4
$108K Buy
1,605
+34
+2% +$2.3K 0.01% 393
2021
Q3
$108K Hold
1,571
0.01% 875
2021
Q2
$107K Buy
1,571
+1
+0.1% +$71 0.01% 890
2021
Q1
$108K Buy
1,570
+1,514
+2,704% +$103K 0.01% 903
2020
Q4
$4K Hold
56
﹤0.01% 1276
2020
Q3
$3K Sell
56
-5
-8% -$238 ﹤0.01% 1726
2020
Q2
$3K Buy
61
+28
+85% +$1.38K ﹤0.01% 1669
2020
Q1
$1K Buy
33
+16
+94% +$840 ﹤0.01% 2195
2019
Q4
$1K Sell
17
-99
-85% -$5.89K ﹤0.01% 2139
2019
Q3
$7K Buy
116
+21
+22% +$1.25K ﹤0.01% 1643
2019
Q2
$6K Buy
95
+63
+197% +$3.24K ﹤0.01% 1610
2019
Q1
$2K Buy
+32
New +$1.63K ﹤0.01% 1556

Other funds holding IART

Meeder Asset Management's IART Position: Q4 2022 in Review

Meeder Asset Management sold out of Integra LifeSciences (IART) in Q4 2022, closing a stake of 668 shares — an estimated $28K sold.

Meeder Asset Management first reported a position in IART in Q1 2019 and held it in 15 quarters. The position peaked at $108K in Q4 2021. 281 funds tracked by Wall St. Rank hold IART as of Q4 2022.

  • Meeder Asset Management reported no remaining Integra LifeSciences position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 668 Integra LifeSciences shares in Q4 2022, an estimated $28K.
  • Meeder Asset Management first reported a position in Integra LifeSciences in Q1 2019 and held it in 15 quarters.
  • Meeder Asset Management's Integra LifeSciences position peaked at $108K in Q4 2021.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.